Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-May-23 5:37 PM View:  | Cormedix Inc. (CRMD) | 17-May-23 | Grant | 10,000 | $4.37 | $43,735.00 | 1000% 1.0K to 11.0K | |
| 09-May-19 5:43 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 07-May-19 | Payment of Exercise | 21,609 | $13.44 | $290,425.00 | (22%) 100.28K to 78.67K | |
| 09-May-19 5:43 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 07-May-19 | Option Exercise | 83,277 | -- | -- | 490% 17.0K to 100.28K | |
| 12-Mar-19 4:49 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 12-Mar-19 | Market Purchase | 17,000 | $11.92 | $202,640.00 | 100% 0 to 17.0K | 3% |
| 02-Jan-18 4:41 PM View: | Allergan Plc (AGN) | 29-Dec-17 | Payment of Exercise | 2,149 | $163.58 | $351,533.00 | (3%) 68.8K to 66.65K | 10% |
| 30-Oct-17 9:22 PM View: | Allergan Plc (AGN) | 26-Oct-17 | Option Exercise | 12,427 | -- | -- | 22% 56.37K to 68.8K | |
| 04-Apr-17 4:23 PM View: | Allergan Plc (AGN) | 03-Apr-17 | Grant | 7,362 | $237.68 | $1,749,800.00 | 15% 49.01K to 56.37K | (38%) |
| 07-Mar-17 4:54 PM View: | Allergan Plc (AGN) | 05-Mar-17 | Payment of Exercise | 761 | $245.63 | $186,924.00 | (2%) 49.77K to 49.01K | 40% |
| 03-Feb-17 7:56 PM View: | Allergan Plc (AGN) | 01-Feb-17 | Grant | 2,369 | $229.32 | $543,259.00 | 5% 48.2K to 50.57K | (36%) |
| 03-Feb-17 7:56 PM View: | Allergan Plc (AGN) | 01-Feb-17 | Payment of Exercise | 798 | $229.32 | $182,997.00 | (2%) 50.57K to 49.77K | 36% |
| 09-Mar-15 6:05 PM View: | Allergan Plc (AGN) | 05-Mar-15 | Grant | 4,568 | -- | -- | 10% 44.64K to 49.2K | |
| 09-Mar-15 6:05 PM View: | Allergan Plc (AGN) | 05-Mar-15 | Payment of Exercise | 1,004 | $295.70 | $296,883.00 | (2%) 49.2K to 48.2K | 51% |
| 13-May-14 5:21 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 3,383 | $197.05 | $666,620.00 | 8% 41.25K to 44.64K | (26%) |
| 10-Dec-13 4:55 PM View: | Allergan Plc (AGN) | 09-Dec-13 | Market Sale | 8,000 | $166.02 | $1,328,160.00 | (16%) 49.25K to 41.25K | 12% |
| 19-Nov-13 5:35 PM View: | Allergan Plc (AGN) | 15-Nov-13 | Market Sale | 10,000 | $164.44 | $1,644,400.00 | (17%) 59.25K to 49.25K | 11% |
| 13-Nov-13 6:36 PM View: | Allergan Plc (AGN) | 11-Nov-13 | Market Sale | 12,000 | $158.39 | $1,900,680.00 | (17%) 71.25K to 59.25K | 8% |
| 02-Oct-13 9:16 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 71,252 | -- | -- | (100%) 71.25K to 0 | |
| 03-Oct-13 4:32 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 71,252 | -- | -- | 100% 0 to 71.25K | |
| 02-Oct-13 9:16 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Grant | 44,312 | -- | -- | 60% 73.89K to 118.2K | |
| 02-Oct-13 9:16 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Payment of Exercise | 121,951 | $144.00 | $17,560,900.00 | (63%) 193.2K to 71.25K | 83% |
| 02-Oct-13 9:16 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Option Exercise | 75,000 | $86.86 | $6,514,500.00 | 63% 118.2K to 193.2K | |
| 06-Aug-13 3:56 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Aug-13 | Payment of Exercise | 14,564 | $136.02 | $1,981,000.00 | (16%) 88.45K to 73.89K | 82% |
| 08-Mar-13 6:01 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Mar-13 | Grant | 16,135 | -- | -- | 22% 72.32K to 88.45K | |
| 05-Mar-13 7:25 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-13 | Payment of Exercise | 4,834 | $85.54 | $413,500.00 | (6%) 77.15K to 72.32K | 72% |
| 02-Nov-12 12:50 PM View: | Watson Pharmaceuticals Inc. (ACT) | 31-Oct-12 | Grant | 14,543 | -- | -- | 23% 62.61K to 77.15K | |
| 12-Mar-12 2:32 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Mar-12 | Grant | 19,508 | -- | -- | 45% 43.1K to 62.61K | |
| 28-Feb-12 12:24 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-12 | Payment of Exercise | 1,640 | $58.17 | $95,398.80 | (4%) 44.74K to 43.1K | 61% |
| 17-Nov-11 4:09 PM View: | Watson Pharmaceuticals Inc. (ACT) | 16-Nov-11 | Payment of Exercise | 1,622 | $64.52 | $104,651.00 | (3%) 46.37K to 44.74K | 65% |
| 04-Mar-11 4:50 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-11 | Grant | 14,365 | -- | -- | 45% 32.0K to 46.37K | |
| 26-Feb-10 4:31 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-10 | Grant | 10,000 | -- | -- | 45% 22.0K to 32.0K | |
| 17-Nov-09 4:11 PM View: | Watson Pharmaceuticals Inc. (ACT) | 16-Nov-09 | Grant | 22,000 | -- | -- | 100% 0 to 22.0K |